Aldatu Biosciences

Cambridge, MA, 12th March 2015 (download press release .pdf) Aldatu Biosciences, a novel diagnostics platform company focused on improving HIV patient care globally, today announced it has been awarded a Direct-to-Phase …

A $250,000 prize to Aldatu Biosciences announced today from the Verizon Powerful Answers Awards stands to fundamentally change the way HIV treatment is delivered across the world by advancing the development of Aldatu’s affordable HIV drug resistance diagnostic, PANDAA™ HIV6.

Aldatu Biosciences is proud to announce it has been named a 2014 Powerful Answers Award winner in the Healthcare category. Aldatu is one of three winners in the Healthcare category and one of 12 winners total (three in each category). The ideas that win the top prizes of $1 million in each category will be revealed on Jan. 27, 2015 in New York City. The remaining eight winners will receive $250,000 each, for a total of $6 million awarded by Verizon.

On May 21st, MassChallenge announced the 2014 class of companies that will participate in the world’s largest accelerator program for early-stage startups – and Aldatu is on the list. As …

On May 19th, the Harvard Innovation Lab hosted their Demo Day as the concluding event of the 2014 Deans’ Health & Life Sciences Challenge, where Aldatu Biosciences was named the winner of the Bertarelli Foundation Grand Prize.

Aldatu was recently selected as one of the semi-finalists in the Life Sciences track for the MIT $100k business plan competition, the “world leader among university entrepreneurship competitions”. More information: …

Aldatu is thrilled to have been selected as one of six finalists in the 2014 Deans’ Health and Life Sciences challenge at Harvard University. This will be an invaluable experience …

Aldatu is excited to announce our selection for the MassCONNECT mentoring program at the Massachusetts Biotechnology Council (MassBio), which kicked off at this morning’s technology showcase in Kendall Square. Aldatu …